105 related articles for article (PubMed ID: 8237371)
21. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O
Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
[TBL] [Abstract][Full Text] [Related]
22. [Encapsulated papillary carcinoma of the thyroid gland. Particular histological aspect of a case with review of the literature].
Bouziani A; Bassoumi T; Zidi B; Miled I; Kammoun N; Ben Ayed M
Arch Anat Cytol Pathol; 1994; 42(2):113-8. PubMed ID: 7811114
[TBL] [Abstract][Full Text] [Related]
23. Expression of stratified epithelial-type cytokeratins in hyalinizing trabecular adenomas supports their relationship with papillary carcinomas of the thyroid.
Fonseca E; Nesland JM; Sobrinho-Simões M
Histopathology; 1997 Oct; 31(4):330-5. PubMed ID: 9363448
[TBL] [Abstract][Full Text] [Related]
24. Programmed Death - Ligand 1 Expression Distinguishes Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma from Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features.
Fu G; Polyakova O; MacMillan C; Ralhan R; Walfish PG
EBioMedicine; 2017 Apr; 18():50-55. PubMed ID: 28363612
[TBL] [Abstract][Full Text] [Related]
25. Impact of Reclassification on Thyroid Nodules with Architectural Atypia: From Non-Invasive Encapsulated Follicular Variant Papillary Thyroid Carcinomas to Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.
Jeon MJ; Song DE; Jung CK; Kim WG; Kwon H; Lee YM; Sung TY; Yoon JH; Chung KW; Hong SJ; Baek JH; Lee JH; Kim TY; Shong YK; Kim WB
PLoS One; 2016; 11(12):e0167756. PubMed ID: 27936121
[TBL] [Abstract][Full Text] [Related]
26. Hyalinizing trabecular adenoma and papillary carcinoma of the thyroid gland express different cytokeratin patterns.
Hirokawa M; Carney JA; Ohtsuki Y
Am J Surg Pathol; 2000 Jun; 24(6):877-81. PubMed ID: 10843292
[TBL] [Abstract][Full Text] [Related]
27. [Non-incidental papillary microcarcinomas of the thyroid].
Monteros Alvi M; Gonorazky S; Virgili E; Soler G; Fernández M; van Cauwlaert L
Medicina (B Aires); 2008; 68(2):139-43. PubMed ID: 18499963
[TBL] [Abstract][Full Text] [Related]
28. Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma. A clinicopathologic study of 105 consecutive patients.
Katoh R; Sasaki J; Kurihara H; Suzuki K; Iida Y; Kawaoi A
Cancer; 1992 Sep; 70(6):1585-90. PubMed ID: 1516009
[TBL] [Abstract][Full Text] [Related]
29. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
30. Role of Ultrasound in Predicting Tumor Invasiveness in Follicular Variant of Papillary Thyroid Carcinoma.
Hahn SY; Shin JH; Oh YL; Kim TH; Lim Y; Choi JS
Thyroid; 2017 Sep; 27(9):1177-1184. PubMed ID: 28699414
[TBL] [Abstract][Full Text] [Related]
31. Cell kinetics, DNA content and TSH receptor-adenylate cyclase system in differentiated thyroid cancer.
Chang TC; Kuo SH; Liaw KY; Chang CC; Chen FW
Clin Endocrinol (Oxf); 1988 Nov; 29(5):477-84. PubMed ID: 3253029
[TBL] [Abstract][Full Text] [Related]
32. Cytochemical assessments of the nuclear DNA distribution pattern by means of image and flow cytometry in thyroid neoplasms and in non-neoplastic thyroid lesions. A comparative methodological study.
Wallin G; Askensten U; Bäckdahl M; Grimelius L; Lundell G; Auer G
Acta Chir Scand; 1989; 155(4-5):251-8. PubMed ID: 2800873
[TBL] [Abstract][Full Text] [Related]
33. Ret oncogene activation in papillary thyroid carcinoma: prevalence and implication on the histological parameters.
Lam AK; Montone KT; Nolan KA; Livolsi VA
Hum Pathol; 1998 Jun; 29(6):565-8. PubMed ID: 9635675
[TBL] [Abstract][Full Text] [Related]
34. [Cytomorphological characteristics of thyroid papillary carcinoma and their prognostic value].
Knezević-Obad A; Knezević Stromar I
Acta Med Croatica; 2008 Oct; 62(4):365-71. PubMed ID: 19205413
[TBL] [Abstract][Full Text] [Related]
35. [An autopsied case of papillary thyroid carcinoma showing DNA heterogeneity-comparison of DNA content between primary focus and metastatic focus].
Komatsu M; Kobayashi S; Sugenoya A; Masuda H; Takahashi S; Iida F; Ito N
Nihon Geka Gakkai Zasshi; 1992 Feb; 93(2):208-11. PubMed ID: 1552893
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical analysis of expression of bcl-2 protein in papillary carcinomas and papillary microcarcinomas of the thyroid gland.
Mitselou A; Peschos D; Dallas P; Charalabopoulos K; Agnantis NJ; Vougiouklakis T
Exp Oncol; 2004 Dec; 26(4):282-6. PubMed ID: 15627060
[TBL] [Abstract][Full Text] [Related]
37. DNA ploidy and stromal bone formation as prognostic indicators of thyroid papillary carcinoma in aged patients: a retrospective study.
Yamashita H; Noguchi S; Murakami N; Tsuji K; Yamaoka N; Sakamoto A
Acta Pathol Jpn; 1993; 43(1-2):22-7. PubMed ID: 8465653
[TBL] [Abstract][Full Text] [Related]
38. The tall cell variant of papillary carcinoma of the thyroid gland. Comparison with the common form of papillary carcinoma by DNA and morphometric analysis.
Flint A; Davenport RD; Lloyd RV
Arch Pathol Lab Med; 1991 Feb; 115(2):169-71. PubMed ID: 1992985
[TBL] [Abstract][Full Text] [Related]
39. A flow cytometric deoxyribonucleic acid analysis of papillary thyroid carcinoma.
Johannessen JV; Sobrinho-Simões M; Tangen KO; Lindmo T
Lab Invest; 1981 Oct; 45(4):336-41. PubMed ID: 7300245
[TBL] [Abstract][Full Text] [Related]
40. Evaluating the projected surgical impact of reclassifying noninvasive encapsulated follicular variant of papillary thyroid cancer as noninvasive follicular thyroid neoplasm with papillary-like nuclear features.
Mainthia R; Wachtel H; Chen Y; Mort E; Parangi S; Sadow PM; Lubitz CC
Surgery; 2018 Jan; 163(1):60-65. PubMed ID: 29146229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
